The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
MABION
+ business areaBioPharma R&D+Services
2021 – 36,060,000 PLN
2022 – 163,980,000 PLN
2023 – 151,680,000 PLN
2024 – 69,020,000 PLN
2020 – 213
2021 – 244
2022 – 255
2023 – 247
2024 – 213
2019 – 11,110,000 PLN
2020 – 9,829,000 PLN
2021 – 8,846,000 PLN
2022 – 6,977,000 PLN
2023 – 7,200,000 PLN
2024 – 8,703,000 PLN
Mabion is a fully integrated CDMO offering a wide array of services associated with the development and manufacturing of protein-based biotherapeutics, including monoclonal antibodies and vaccine antigens. Mabion offers an end-to-end solution, covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process scale-up, large-scale DS and DP manufacturing and quality control down to sterile fill-finish in accordance with ISO and GMP. We also provide packaging and serialization, bioanalytical and regulatory support services.